Literature DB >> 11237124

Myocardial microangiopathy associated with antiphospholipid antibodies.

B R Lauwerys1, M Lambert, J L Vanoverschelde, J P Cosyns, F A Houssiau.   

Abstract

Myocardial thrombotic microangiopathy is a well described post-mortem finding in patients with the catastrophic antiphospholipid (APL) syndrome. However, it has been only very rarely imaged in living patients. Here, we report two patients with APL antibodies presenting with scintigraphic, electrocardiographic and/or echocardiographic evidence of (sub)acute myocardial ischaemia, despite a normal coronary angiography. Formal proof of a thrombotic microangiopathy was obtained by a kidney biopsy in one patient. We emphasize the value of 99mTc-MIBI (2-methoxy isobutyl isonitrile) exercise stress myocardial scintigraphy for the detection of cardiac microangiopathy associated with the APL syndrome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11237124     DOI: 10.1191/096120301666383277

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  4 in total

1.  Echocardiographic Assessment of Diastolic Function in Children with Incident Systemic Lupus Erythematosus.

Authors:  Joyce C Chang; Brian R White; Matthew D Elias; Rui Xiao; Andrea M Knight; Pamela F Weiss; Laura Mercer-Rosa
Journal:  Pediatr Cardiol       Date:  2019-04-30       Impact factor: 1.655

2.  Comparison of Tc-99m tetrofosmin myocardial perfusion scintigraphy and exercise F18-FDG imaging in detection of myocardial ischemia in patients with coronary artery disease.

Authors:  Sasikumar Arun; Bhagwant Rai Mittal; Anish Bhattacharya; Manoj Kumar Rohit
Journal:  J Nucl Cardiol       Date:  2014-08-15       Impact factor: 5.952

Review 3.  The digestive system involvement of antiphospholipid syndrome: pathophysiology, clinical characteristics, and treatment strategies.

Authors:  Jin Zhang; Cheng Li; Xiaorong Han; Zhongbo Chen; Binay Kumar Adhikari; Yinghui Wang; Yonggang Wang; Jian Sun
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

Review 4.  Cardiac Manifestations of Antiphospholipid Syndrome With Focus on Its Primary Form.

Authors:  Tamara Kolitz; Shachaf Shiber; Itzhak Sharabi; Asher Winder; Gisele Zandman-Goddard
Journal:  Front Immunol       Date:  2019-05-10       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.